The unified bit-level domain injection using XOR with molecular fingerprints and Metropolis scoring for chemical property optimization offers a seamless pipeline for domain adaptation inside the core framework. This is directly relevant to landmark quantum-biomedical collaborations announced in 2025.[^6_2][^6_1]

